TRI-611

N/A

Report date: 2026/03/26 20:00:17
NME

Base Information

Drug NameTRI-611
Drug Alias NameTRI-611
ClassificationSmall molecules > Molecular Glue
Mechanisms of ActionAnaplastic lymphoma kinase degraders
TargetsAnaplastic lymphoma kinase
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTRIANA Biomedicines Inc
China Registration ClassN/A

Develop Information

Active CompaniesTRIANA Biomedicines Inc
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell LungLung Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A